X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE AJANTA PHARMA SUVEN LIFE/
AJANTA PHARMA
 
P/E (TTM) x 16.6 20.1 82.5% View Chart
P/BV x 3.1 8.7 35.4% View Chart
Dividend Yield % 1.2 0.7 176.3%  

Financials

 SUVEN LIFE   AJANTA PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
AJANTA PHARMA
Mar-16
SUVEN LIFE/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3391,720 19.7%   
Low Rs1441,103 13.1%   
Sales per share (Unadj.) Rs39.2194.6 20.2%  
Earnings per share (Unadj.) Rs7.545.2 16.5%  
Cash flow per share (Unadj.) Rs8.850.3 17.4%  
Dividends per share (Unadj.) Rs2.008.00 25.0%  
Dividend yield (eoy) %0.80.6 146.1%  
Book value per share (Unadj.) Rs49.0132.0 37.1%  
Shares outstanding (eoy) m127.2888.77 143.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.27.3 84.8%   
Avg P/E ratio x32.431.2 103.7%  
P/CF ratio (eoy) x27.528.1 98.0%  
Price / Book Value ratio x4.910.7 46.1%  
Dividend payout %26.817.7 151.5%   
Avg Mkt Cap Rs m30,732125,299 24.5%   
No. of employees `0001.0NA-   
Total wages/salary Rs m4162,570 16.2%   
Avg. sales/employee Rs Th5,236.1NM-  
Avg. wages/employee Rs Th436.5NM-  
Avg. net profit/employee Rs Th995.5NM-  
INCOME DATA
Net Sales Rs m4,99517,275 28.9%  
Other income Rs m194166 116.4%   
Total revenues Rs m5,18917,442 29.7%   
Gross profit Rs m1,2335,807 21.2%  
Depreciation Rs m167451 37.1%   
Interest Rs m5449 110.8%   
Profit before tax Rs m1,2055,474 22.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2551,460 17.5%   
Profit after tax Rs m9504,014 23.7%  
Gross profit margin %24.733.6 73.4%  
Effective tax rate %21.226.7 79.4%   
Net profit margin %19.023.2 81.8%  
BALANCE SHEET DATA
Current assets Rs m4,9867,639 65.3%   
Current liabilities Rs m1,0422,715 38.4%   
Net working cap to sales %79.028.5 277.0%  
Current ratio x4.82.8 170.0%  
Inventory Days Days6143 141.1%  
Debtors Days Days3979 49.7%  
Net fixed assets Rs m3,1266,914 45.2%   
Share capital Rs m127177 72.0%   
"Free" reserves Rs m3,71711,442 32.5%   
Net worth Rs m6,23611,721 53.2%   
Long term debt Rs m432149 290.7%   
Total assets Rs m8,07914,814 54.5%  
Interest coverage x23.2112.9 20.6%   
Debt to equity ratio x0.10 546.4%  
Sales to assets ratio x0.61.2 53.0%   
Return on assets %12.427.4 45.3%  
Return on equity %15.234.2 44.5%  
Return on capital %18.946.5 40.6%  
Exports to sales %87.555.1 158.7%   
Imports to sales %12.26.0 203.6%   
Exports (fob) Rs m4,3719,527 45.9%   
Imports (cif) Rs m6111,038 58.9%   
Fx inflow Rs m4,66610,422 44.8%   
Fx outflow Rs m9421,678 56.1%   
Net fx Rs m3,7248,744 42.6%   
CASH FLOW
From Operations Rs m9223,264 28.2%  
From Investments Rs m-619-2,093 29.6%  
From Financial Activity Rs m-698-1,186 58.9%  
Net Cashflow Rs m-396-15 2,673.6%  

Share Holding

Indian Promoters % 63.4 73.8 85.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.6 -  
FIIs % 0.0 7.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.0 214.7%  
Shareholders   37,287 20,968 177.8%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 21, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - FULFORD INDIA COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS